LUC00117I2 - - Google Patents

Info

Publication number: LUC00117I2
Authority: LU; Luxembourg

Application number

LU00117C

Original Assignee

Oasmia Pharmaceutical Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-19

Filing date

2019-05-03

Publication date

2024-05-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40795732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LUC00117(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-05-03 Application filed by Oasmia Pharmaceutical Ab filed Critical Oasmia Pharmaceutical Ab

2024-05-22 Publication of LUC00117I2 publication Critical patent/LUC00117I2/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Physics & Mathematics (AREA)
Biomedical Technology (AREA)
Nanotechnology (AREA)
Optics & Photonics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Transplantation (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

LU00117C 2007-12-19 2019-05-03 LUC00117I2 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/SE2007/001127 WO2009078754A1 (fr)	2007-12-19	2007-12-19	Système d'administration de médicament permettant d'administrer des substances pharmaceutiquement actives faiblement hydrosolubles

Publications (1)

Publication Number	Publication Date
LUC00117I2 true LUC00117I2 (fr)	2024-05-22

Family

ID=40795732

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU00117C LUC00117I2 (fr)	2007-12-19	2019-05-03

Country Status (27)

Country	Link
US (4)	US8999382B2 (fr)
EP (1)	EP2231189B1 (fr)
JP (1)	JP5466172B2 (fr)
KR (1)	KR101572703B1 (fr)
CN (1)	CN101951956B (fr)
AU (1)	AU2008339099B2 (fr)
BR (1)	BRPI0821740B1 (fr)
CA (1)	CA2709266C (fr)
CY (2)	CY1119805T1 (fr)
DK (1)	DK2231189T3 (fr)
EA (1)	EA015247B1 (fr)
ES (1)	ES2650242T3 (fr)
FR (1)	FR19C1030I1 (fr)
HR (1)	HRP20171796T1 (fr)
HU (1)	HUE034684T2 (fr)
LT (2)	LT2231189T (fr)
LU (1)	LUC00117I2 (fr)
MX (1)	MX2010006914A (fr)
MY (2)	MY157187A (fr)
NL (1)	NL300987I9 (fr)
NO (2)	NO2231189T3 (fr)
NZ (1)	NZ586859A (fr)
PL (1)	PL2231189T3 (fr)
PT (1)	PT2231189T (fr)
SI (1)	SI2231189T1 (fr)
WO (2)	WO2009078754A1 (fr)
ZA (1)	ZA201004685B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009078756A1 (fr)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Système d'administration de médicament pour administrer une substance pharmaceutiquement acceptable amphiphile, cationique et hydrosoluble
WO2009078755A1 (fr)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Système d'administration de médicament pour administrer une substance pharmaceutiquement active amphiphile, cationique et hydrosoluble
WO2009078754A1 (fr) *	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Système d'administration de médicament permettant d'administrer des substances pharmaceutiquement actives faiblement hydrosolubles
JP2012524780A (ja) *	2009-04-21	2012-10-18	セレクタバイオサイエンシーズインコーポレーテッド	Ｔｈ１バイアス応答をもたらす免疫ナノ治療薬（Ｉｍｍｕｎｏｎａｎｏｔｈｅｒａｐｅｕｔｉｃｓ）
WO2011150258A1 (fr)	2010-05-26	2011-12-01	Selecta Biosciences, Inc.	Sélection de dose de nanovecteurs synthétiques avec adjuvant
EA201390660A1 (ru)	2010-11-05	2013-11-29	Селекта Байосайенсиз, Инк.	Модифицированные никотиновые соединения и связанные способы
CN103908432B (zh) *	2013-01-02	2018-09-21	博瑞生物医药（苏州）股份有限公司	一种伊沙匹隆白蛋白的冻干组合物及其制备方法
CN112239418B (zh) *	2019-07-18	2023-07-07	上海现代药物制剂工程研究中心有限公司	视黄醇类化合物及其钠盐的制备方法
CN112321465B (zh) *	2019-07-18	2023-06-06	上海现代药物制剂工程研究中心有限公司	一种含苯基化合物、其中间体、制备方法及应用
WO2021259472A1 (fr) *	2020-06-24	2021-12-30	Oasmia Pharmaceutical Ab	Docétaxel micellaire à utiliser dans le traitement du cancer
CN115429886B (zh) *	2021-06-02	2025-10-31	复旦大学	一种药物纳米结晶制剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6096331A (en) *	1993-02-22	2000-08-01	Vivorx Pharmaceuticals, Inc.	Methods and compositions useful for administration of chemotherapeutic agents
DE19839566C2 (de) *	1998-08-31	2002-01-17	Fumapharm Ag Muri	Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
US6197809B1 (en) *	1998-12-23	2001-03-06	Ardenia Investments Ltd.	Compounds for the treatment of cancer
US6656504B1 (en) *	1999-09-09	2003-12-02	Elan Pharma International Ltd.	Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
SE0101702D0 (sv) *	2001-05-15	2001-05-15	Ardenia Investments Ltd	Novel potentiating compounds
US20050249786A1 (en) *	2001-09-28	2005-11-10	Solubest Ltd.	Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
US20050191359A1 (en) *	2001-09-28	2005-09-01	Solubest Ltd.	Water soluble nanoparticles and method for their production
EP1534672B1 (fr) *	2002-07-23	2013-05-01	Ardenia Investments Ltd.	Derives de retinol, leur utilisation dans le traitement du cancer et la potentialisation de l'efficacite d'autres agents cytotoxiques
SE0202311D0 (sv) *	2002-07-23	2002-07-23	Ardenia Investments Ltd	Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
US7259984B2 (en) *	2002-11-26	2007-08-21	Cornell Research Foundation, Inc.	Multibit metal nanocrystal memories and fabrication
JP2006199590A (ja)	2003-09-04	2006-08-03	Nano Career Kk	水溶性の塩基性薬物内包ナノ粒子含有組成物
WO2005089106A2 (fr)	2004-02-27	2005-09-29	Molecular Therapeutics, Inc.	Nanoparticules degradables
US7871632B2 (en)	2004-07-12	2011-01-18	Adventrx Pharmaceuticals, Inc.	Compositions for delivering highly water soluble drugs
US8945629B2 (en) *	2004-09-10	2015-02-03	University Of Wyoming	Nanoparticles for cytoplasmic drug delivery to cancer cells
KR101643416B1 (ko) *	2005-08-31	2016-07-27	아브락시스 바이오사이언스, 엘엘씨	증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조방법
WO2009078755A1 (fr)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Système d'administration de médicament pour administrer une substance pharmaceutiquement active amphiphile, cationique et hydrosoluble
WO2009078754A1 (fr)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Système d'administration de médicament permettant d'administrer des substances pharmaceutiquement actives faiblement hydrosolubles
WO2009078756A1 (fr)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Système d'administration de médicament pour administrer une substance pharmaceutiquement acceptable amphiphile, cationique et hydrosoluble

2007
- 2007-12-19 WO PCT/SE2007/001127 patent/WO2009078754A1/fr not_active Ceased
2008
- 2008-12-18 DK DK08861526.5T patent/DK2231189T3/en active
- 2008-12-18 CN CN2008801270180A patent/CN101951956B/zh active Active
- 2008-12-18 US US12/809,252 patent/US8999382B2/en active Active
- 2008-12-18 LT LTEP08861526.5T patent/LT2231189T/lt unknown
- 2008-12-18 PL PL08861526T patent/PL2231189T3/pl unknown
- 2008-12-18 EP EP08861526.5A patent/EP2231189B1/fr active Active
- 2008-12-18 JP JP2010539385A patent/JP5466172B2/ja active Active
- 2008-12-18 NZ NZ586859A patent/NZ586859A/en unknown
- 2008-12-18 SI SI200831891T patent/SI2231189T1/en unknown
- 2008-12-18 MY MYPI2010002786A patent/MY157187A/en unknown
- 2008-12-18 MX MX2010006914A patent/MX2010006914A/es active IP Right Grant
- 2008-12-18 HU HUE08861526A patent/HUE034684T2/en unknown
- 2008-12-18 HR HRP20171796TT patent/HRP20171796T1/hr unknown
- 2008-12-18 AU AU2008339099A patent/AU2008339099B2/en active Active
- 2008-12-18 WO PCT/SE2008/051515 patent/WO2009078802A1/fr not_active Ceased
- 2008-12-18 ES ES08861526.5T patent/ES2650242T3/es active Active
- 2008-12-18 CA CA2709266A patent/CA2709266C/fr active Active
- 2008-12-18 PT PT88615265T patent/PT2231189T/pt unknown
- 2008-12-18 BR BRPI0821740-8A patent/BRPI0821740B1/pt active IP Right Grant
- 2008-12-18 KR KR1020107015610A patent/KR101572703B1/ko active Active
- 2008-12-18 MY MYPI2010002787A patent/MY157186A/en unknown
- 2008-12-18 NO NO08861526A patent/NO2231189T3/no unknown
- 2008-12-18 EA EA200802350A patent/EA015247B1/ru unknown
2010
- 2010-07-02 ZA ZA2010/04685A patent/ZA201004685B/en unknown
2015
- 2015-02-27 US US14/633,177 patent/US9993438B2/en not_active Ceased
2017
- 2017-12-04 CY CY20171101264T patent/CY1119805T1/el unknown
2019
- 2019-04-24 CY CY2019021C patent/CY2019021I2/el unknown
- 2019-04-25 LT LTPA2019508C patent/LTPA2019508I1/lt unknown
- 2019-05-03 LU LU00117C patent/LUC00117I2/fr unknown
- 2019-05-06 NL NL300987C patent/NL300987I9/nl unknown
- 2019-05-06 FR FR19C1030C patent/FR19C1030I1/fr active Active
- 2019-05-08 NO NO2019023C patent/NO2019023I1/no unknown
2020
- 2020-06-12 US US16/899,848 patent/USRE49741E1/en active Active
2021
- 2021-02-17 US US17/177,550 patent/USRE49742E1/en active Active

Also Published As

Publication number	Publication date
JP2011507838A (ja)	2011-03-10
MY157187A (en)	2016-05-13
EP2231189B1 (fr)	2017-09-06
US9993438B2 (en)	2018-06-12
AU2008339099A1 (en)	2009-06-25
NO2231189T3 (fr)	2018-02-03
NL300987I9 (nl)	2019-05-16
US8999382B2 (en)	2015-04-07
LT2231189T (lt)	2017-12-27
CA2709266C (fr)	2017-09-26
USRE49741E1 (en)	2023-12-05
JP5466172B2 (ja)	2014-04-09
CN101951956B (zh)	2012-10-17
BRPI0821740B1 (pt)	2021-05-18
ZA201004685B (en)	2011-03-30
EP2231189A1 (fr)	2010-09-29
MY157186A (en)	2016-05-13
EP2231189A4 (fr)	2013-10-09
KR101572703B1 (ko)	2015-11-27
CA2709266A1 (fr)	2009-06-25
WO2009078802A1 (fr)	2009-06-25
USRE49742E1 (en)	2023-12-05
WO2009078754A1 (fr)	2009-06-25
EA200802350A3 (ru)	2009-10-30
NL300987I2 (fr)	2019-05-09
ES2650242T3 (es)	2018-01-17
CY2019021I1 (el)	2019-11-27
LTPA2019508I1 (lt)	2019-05-10
US20150164819A1 (en)	2015-06-18
PT2231189T (pt)	2017-12-12
PL2231189T3 (pl)	2018-03-30
EA200802350A2 (ru)	2009-06-30
HUE034684T2 (en)	2018-02-28
CY2019021I2 (el)	2019-11-27
EA015247B1 (ru)	2011-06-30
FR19C1030I1 (fr)	2019-06-21
SI2231189T1 (en)	2018-03-30
KR20100094575A (ko)	2010-08-26
DK2231189T3 (en)	2017-12-11
HRP20171796T1 (hr)	2018-01-26
NZ586859A (en)	2012-06-29
AU2008339099B2 (en)	2015-08-13
NO2019023I1 (no)	2019-05-08
CN101951956A (zh)	2011-01-19
MX2010006914A (es)	2010-11-10
CY1119805T1 (el)	2018-06-27
BRPI0821740A2 (pt)	2020-02-27
US20110014281A1 (en)	2011-01-20

Publication	Publication Date	Title
NL300987I2 (fr)	2019-05-09
CN300828568S (zh)	2008-09-10	吊顶面板(i)
CN300727131S (zh)	2008-01-02	包装袋
CN300727183S (zh)	2008-01-02	包装袋(谷满多生物有机肥)
CN300952491S (zh)	2009-07-01	展台(寰宇之星)
CN300919244S (zh)	2009-05-06	自储式刀柄
CN300898568S (zh)	2009-04-01	服装面料(2007022)
CN300894950S (zh)	2009-03-25	女式羊毛衫(1)
CN300880645S (zh)	2009-02-04	包装盒(6)
CN300878583S (zh)	2009-01-28	碗(yl789095)
CN300727301S (zh)	2008-01-02	电梯开门机的门刀(2)
CN300849938S (zh)	2008-11-19	楼宇对讲可视分机(cm)
CN300822791S (zh)	2008-08-27	落地灯(1)
CN300816292S (zh)	2008-08-13	麻将牌坯
CN300810034S (zh)	2008-07-30	名片纸(异形14)
CN300806407S (zh)	2008-07-23	包装盒
CN300805372S (zh)	2008-07-23	面料(4)
CN300801297S (zh)	2008-07-09	酒标贴（4）
CN300769776S (zh)	2008-04-23	移动视频通讯信息主机和子机
CN300760399S (zh)	2008-04-02	提篮(a)
CN300758104S (zh)	2008-03-26	镶嵌玻璃(205)
CN300741280S (zh)	2008-02-06	包装盒(2)
CN300729958S (zh)	2008-01-09	墙壁组合开关插座
CN300729714S (zh)	2008-01-09	首饰链(hy-an0023)
CN300729514S (zh)	2008-01-09	包装盒